Know Cancer

or
forgot password


N/A
18 Years
80 Years
Open (Enrolling by invite only)
Female
CIN, Cervical Cancer

Thank you

Trial Information


Inclusion Criteria:



- Women between 18 and 80

- Karnofsky-Index of 80 and higher

- Cytological suspicious CIN and a colposcopical impression of a major lesion
(therapeutical endpoint: conisation)

Exclusion Criteria:

- Former malign disease oft he pelvic organs

- Pregnancy

- Serious internistic diseases

- Drug addiction

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

pathological comparative results and all cause mobidity

Outcome Description:

The comparison of these two methods to show that the pathologic diagnostical results are alike and the morbidity is less.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Achim Schneider, Prof. Dr., MPH

Investigator Role:

Study Chair

Investigator Affiliation:

Charité University Berlin, Germany

Authority:

Germany: Ethics Commission

Study ID:

CX-CUR

NCT ID:

NCT01836588

Start Date:

March 2013

Completion Date:

April 2014

Related Keywords:

  • CIN
  • Cervical Cancer
  • Uterine Cervical Neoplasms

Name

Location